Indivior PLC revised earnings guidance for the year 2021. For the year, the company expects total net revenue to be between $750 million to $770 million. This is based on the company?s expectations for continued sequential net revenue growth of SUBLOCADE and an essentially unchanged U.S. share position for SUBOXONE Film for the remainder of the year of around 20%. The midpoint of the company?s revised total net revenue guidance, $760 million, would represent an approximately 18% increase versus full year 2020 net revenue of $647 million.